Developer of cellular drug discovery tools designed to provide medicines for cancer treatment.
Drug Discovery📍 South San Francisco, CAFounded 2018
Current Valuation
$1.9B
as of 2024-Q3
UNICORN
Developer of cellular drug discovery tools designed to provide medicines for cancer treatment.
Company Profile
Founded
2018
HQ
South San Francisco, CA
Employees
216
Total Raised
$630.81M
Last Round
Series C — $325M (Sep 2024)
IPO Status
private
Fundraising Status
Series C · $325M · 1y 11mo ago
privateTotal raised $630.81M
Secondary Market
Implied price / share
$15.59
Last round price / share
$18.58
vs last round
-16.1%
Open interest
1
Last round price vs secondary price
Secondary price return by period
Implied per-share price from private secondary transactions, as of Jun 2026. This is a point estimate, not a quote — the feed carries no bid, ask or spread, and a secondary print is evidence of what someone paid on that date rather than a live market. Compare across every tracked name →
Private-company numbers are not real-time. Reflects publicly disclosed valuations from press releases, news reports, and tender offers as of 2024-Q3. Refreshed quarterly.